sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross

$766,144

Mark T Heise · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI

Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms

$766,078

Louise Deborah McCullough · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · MH

Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses

$766,055

Lanying Du · Georgia State University · R01 · FY2021 · AI

Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome

$765,082

Yuan Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI

Elucidation of Assembly and Budding Mechanisms of SARS-CoV-2

$765,004

Robert Virgil Stahelin · Purdue University · R01 · FY2024 · AI

ECMO without Anticoagulation

$764,547

Robert H. Bartlett · University Of Michigan At Ann Arbor · R01 · FY2022 · HL

COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)

$764,466

Lawrence C Kleinman · Rbhs-Robert Wood Johnson Medical School · R61 · FY2022 · HD

Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases

$763,801

Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2021 · AI

Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases

$763,801

Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2022 · AI

Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases

$763,801

Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2024 · AI

Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases

$763,801

Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2025 · AI

Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases

$763,801

Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2023 · AI

Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women

$763,431

Tenã T Lewis · Emory University · R01 · FY2024 · HL

Leveraging Extensive Social Determinants Data and Spatial Data Science to Reduce HIV Incidence across the United States Ending the HIV Epidemic Counties

$763,331

Yusuf Ransome · Yale University · R01 · FY2025 · MH

Elucidation of Assembly and Budding Mechanisms of SARS-CoV-2

$763,024

Robert Virgil Stahelin · Purdue University · R01 · FY2025 · AI

Inborn errors of immunity in patients with life-threatening COVID-19

$762,750

Jean-Laurent Casanova · Rockefeller University · R01 · FY2021 · AI

Early life B cell responses and inflammation following SARS-CoV-2 infection

$762,710

Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI

Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike

$762,466

Priyamvada Acharya · Duke University · R01 · FY2023 · AI

Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike

$762,466

Priyamvada Acharya · Duke University · R01 · FY2022 · AI

Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike

$762,305

Priyamvada Acharya · Duke University · R01 · FY2024 · AI

Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions

$762,178

Frederick R Haselton · Vanderbilt University · R01 · FY2024 · AI

SARS-CoV-2 Genomic Surveillance and Epidemiology in New Mexico

$762,082

Matthew J Campen · University Of New Mexico Health Scis Ctr · P20 · FY2022 · GM

Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross

Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms

Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses

Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome

Elucidation of Assembly and Budding Mechanisms of SARS-CoV-2

ECMO without Anticoagulation

COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)

Initiation of immune responses to SARS COV2 in the oral cavity and upper airway

Novel delivery platform and antigen design for an effective COVID-19 vaccine

Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD

Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases

Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases

Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases

Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases

Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases

Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women

Leveraging Extensive Social Determinants Data and Spatial Data Science to Reduce HIV Incidence across the United States Ending the HIV Epidemic Counties

Elucidation of Assembly and Budding Mechanisms of SARS-CoV-2

Inborn errors of immunity in patients with life-threatening COVID-19

Early life B cell responses and inflammation following SARS-CoV-2 infection

Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike

Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike

Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike

Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions

SARS-CoV-2 Genomic Surveillance and Epidemiology in New Mexico